Full coverage· Security· Updated
Teva Pharmaceuticals Expresses Disappointment Over Irish Consultants' Boycott
Teva Pharmaceuticals expressed disappointment after the Irish Hospital Consultants Association voted to encourage a boycott of its products due to ethical concerns related to the Gaza conflict. The boycott, proposed by consultant Thomas Donnelly, could affect 12.5% of Irish prescriptions.
2 newsrooms · 1 language · since
Plus
What happened
- 01Teva Pharmaceuticals is disappointed by the Irish Hospital Consultants Association's boycott motion.
- 02The boycott affects 12.5% of Irish prescriptions and is due to ethical concerns over the Gaza conflict.
- 03Consultant Thomas Donnelly proposed the motion, citing his inability to use Teva products indirectly linked to conflict.
- 04Teva emphasizes patient care and clinical evidence over politicized healthcare decisions.
- 05The IHCA will defend clinicians who refuse to use Teva products when alternatives exist.
- 06UK medical bodies recently ended commercial partnerships with Teva UK.
Teva stated its commitment to patient care and working with Irish healthcare professionals, while the IHCA pledged to defend clinicians who participate in the boycott.
The Jerusalem Post publishes in English. The key points are summarized above. Read The Jerusalem Post’s full report from the link below.
The coverage
2 newsrooms on this story
Who covered it
- LeftNone
- Centre1
- Right1
- HarediNone
- ArabNone
How it broke
See which of the 2 newsrooms broke it, and who waited